DRUG
Ipamorelin
IV
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Status
Completed
Phase
Phase 2
Enrollment
117
Locations
19
Results
Not posted
Publications
1
Study summary
What the protocol is testing.
The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
Full detailed description
The safety and efficacy of ipamorelin in the management of post-operative ileus
Interventions
Treatment arms and agents.
DRUG
placebo
IV
Timeline
From registration to results.
First posted
May 6, 2008
Study start
Apr 2008
Primary completion
Dec 2009
Study completion
Dec 2009
Results posted
Not reported
Registry updated
Apr 14, 2017
Outcomes
What the study measures.
Primary outcomes
Recovery of GI function
Time frame · Until hospital discharge
Secondary outcomes
Not reported in the indexed record.
Eligibility
Who can take part.
- Minimum age
- 18 Years
- Maximum age
- 85 Years
- Sex
- ALL
- Healthy volunteers
- No
Inclusion Criteria: * willing to comply with protocol * undergoing bowel resection surgery * ASA Class I-III * Females must not be pregnant * Body weight 40-150 kg Exclusion Criteria: * mentally incompetent or unable to provide informed consent * clinically unstable * significant liver disease * clinically significant lab or EKG abnormalities * alcohol or illicit drug abuse * history of or current surgery that would prevent proper evaluation of safety or efficacy of drug
Study locations
19 registered sites.
United States. Showing up to 24 locations stored in the fast local snapshot.
USC/Norris Cancer Center
Los Angeles, California, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
Palo Alto Veterans Hospital
Palo Alto, California, United States
University of Colorado Hospital
Aurora, Colorado, United States
Denver VA Hospital
Denver, Colorado, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Cleveland Clinic of Weston
Weston, Florida, United States
St. Joseph's Hospital of Atlanta
Atlanta, Georgia, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Indiana University Medical Center
Indianapolis, Indiana, United States
Ochsner Medical Center
New Orleans, Louisiana, United States
UMass Memorial Healthcare
Worcester, Massachusetts, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
Barnes Jewish Hospital
St Louis, Missouri, United States
Stony Brook University Medical Center
Stony Brook, New York, United States
The Christ Hospital
Cincinnati, Ohio, United States
University Hospitals Case Medical Center
Cleveland, Ohio, United States
The Pennsylvania State University
Hershey, Pennsylvania, United States
St. Joseph Hospital
Tacoma, Washington, United States
Related trials
More studies on Ipamorelin.
NCT IDStudyPhase / statusEnrollmentUpdated
Trifecta Research Study
Axial Therapeutic Research · PTSD - Post Traumatic Stress Disorder · Cognitive Dysfunction
Not applicable
Active, not recruiting
52
2026-07
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Helsinn Therapeutics (U.S.), Inc · Gastrointestinal Dysmotility
Phase 2
Completed
320
2017-04
Related PeptideStat pages
Put the record in context.
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.